Session date: 
02/02/2022 - 12:00pm to 1:00pm EST

David Spigel, MD 

Professor of Medicine and Oncology

Enterprise Chief of Cardio-Oncology

Attending, Program in Heart Failure and Transplantation

Jefferson Heart Institute

Department of Medicine


Spigel joined Sarah Cannon in 2003 and as chief scientific officer, he oversees all scientific aspects of Sarah Cannon's clinical trial program, working with the research physician leaders to ensure the best new agents and studies are available to our patients. He serves as a primary contact for the Pharma and biotech partners as well as the strategic site physicians with whom Sarah Cannon conducts cancer research.  


Spigel received his bachelor’s degree from Tulane University in New Orleans in 1992, and medical degree from The University of Tennessee in Memphis in 1996. After completing an internal medicine and chief residency at Indiana University Medical Center, he completed a fellowship in hematology and oncology at The Dana-Farber Cancer Institute in Boston. He is board certified in medical oncology. Additionally, he is a partner with Tennessee Oncology, PLLC.


Zoom Meeting ID: 970 9286 7526
233 South 10th Street
Passcode: 271149
United States
Session Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance

Please login or register to take this course.